Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income Countries

Recruiting Observational Study
Drug Use Hepatitis Hiv
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
2,400 (estimated)
Sponsor
Médecins du Monde · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Implementation and evaluation of a distribution program for low dead-space syringes/needles (LDSS/N) in Armenia, Georgia, and Tanzania, Egypt, Nigeria, Vietnam, India, Ukraine, and South Africa. This study aims to generate evidence on best practice LDSS/N distribution programs which will enhance acceptability and sustain high levels of LDSS/N uptake. People who inject drugs and access needle and …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Aged ≥18 years (note that country-specific protocols may include participants aged ≥16 where appropriate and relevant); * Reporting a history of recent (past month) injection drug use; * Accessing the NSP to receive injecting equipment at either a facility, mobile service or t…
Contacts

Bridget Draper

+61 413 272 698

bridget.draper@burnet.edu.au

CONTACT

Mark Stoové

mark.stoove@burnet.edu.au

CONTACT